January Scientific Highlights

Newly Funded Scientists Tackle Basic Cancer Research at Molecular Level

Virtually every drug, therapy, and diagnostic test that is used in the clinic today originated from basic, laboratory research. We cannot cure cancer, if we don’t understand what causes it. Although basic, fundamental research may not effect an immediate cure, expanding our knowledge of cancer’s underlying processes will eventually lead to that “eureka” moment. Below is information on the research work of three ICRF scientists in their first year of funding who are confronting the cancer problem at the molecular level. 

Yitzhak Reizel, PhD

Technion, Israel Institute of Technology
ICRF Research Career Development Award Recipient

Learn More

Yarden Opatowsky, PhD
Bar-Ilan University
ICRF Project Grant Recipient

Learn More

Julia Shifman, PhD
Ben-Gurion University of the Negev
ICRF Project Grant Recipient

Learn More

RNA-Based Cancer Treatments Focus of Research Professorship Grant

Rotem Karni, PhD, of Hebrew University-Hadassah Medical School, spoke to ICRF about how his ICRF-Glazer Foundation Research Professorship Grant will enable him to explore several promising RNA-based technologies to target cancer cells.